Verge Genomics

We use human data and AI to develop better drugs faster.

South San Francisco, United States · Founded 2015 · $176.1M raised

Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$176.1M
Last Round
$42.0M Corporate RoundSep 2023
Rounds
5

About

Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.

Summary

Verge Genomics is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $176.1M in total across 5 rounds, most recently a $42.0M Corporate Round round in Sep 2023. Investors include ALS Investment Fund, IA Ventures and Two Sigma Ventures.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundSep 2023
$42.0M

Sign up to see all 5 rounds

Seed through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Verge Genomics on Indexed.vc
<a href="https://indexed.vc/companies/verge-genomics"><img src="https://indexed.vc/api/badge/company/verge-genomics" alt="Verge Genomics on Indexed.vc" width="260" height="76" /></a>